Imagine cancer treatment that selectively killed regular cancer cells, and also the cancer stem cells that cause tumors to regrow.
Imagine that we had the ability to do more than just prolong life or to delay the inevitable by a matter of months… but to provide a therapy that delivered long-term remission. Imagine being able to face that therapy without wondering if the benefits were worth the down-side of debilitating side-effects.
This is what Novogen imagines. More importantly, Novogen believes that it has the ability to convert that imagination into reality.
Novogen has invented a breakthrough technology that allows previously-inflexible drug scaffolds to be twisted and shaped to improve their ability to seek out cancer cells, as well as allowing the insertion of beneficial atoms that was not possible before. The result has been a dramatic increase in anti-cancer potency against both regular cancer cells and cancer stem cells.
Our first lead drug, Trilexium, kills ovarian cancer stem cells quickly and efficiently.
We firmly believe we are on the road to conquering cancer. Please bookmark this page and follow our journey. We’ll keep you informed.